Live Breaking News & Updates on Konza valley capital inc
Stay updated with breaking news from Konza valley capital inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Paladin Holdings LLC, a portfolio company of Makai Capital Partners, has acquired Texize, Inc. ("Texize") of Greenville, SC. Texize is a...
LEAWOOD, KS - September 28, 2023 - First Business Bank is pleased to welcome Marshall Parker to First Business Bank's Kansas City Metro Advisory Board.
With a new majority owner, KCAS Bioanalytical readies to double workforce bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Vitruvian Partners announces strategic growth investment in KCAS Bioanalytical and Biomarker Services Vitruvian's acquisition enables KCAS to further accelerate global growth both through acquisitions and expansion of its U.S. operations Vitruvian Partners, one of the world's leading growth-focused investment firms, announced that it has acquired a majority ownership stake in KCAS Bioanalytical and Biomarker Services (KCAS), located in the Kansas City, Kansas metropolitan area. Both management and current majority shareholders KVCI are making a significant reinvestment in the company. Other financial terms of the transaction were not disclosed. KCAS is a leading U.S.-based Contract Research Organization providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and animal health industries. The company offers a complete range of bioanalytical services from early discovery support through registration, providing expertise in biological (large molecule) and synthetic (small molecule) drug candidates. Vitruvian's investment positions KCAS to continue growing its operations in Kansas City, including with a [70,000] sq ft new facility; continue the rapid hiring of top scientific talent and focus on outstanding customer service; and accelerate internationalization including through acquisitions. Vitruvian's global reach and significant available capital positions KCAS as a platform for accelerated future growth through acquisitions and continued expansion of its current operations.